Literature DB >> 2813359

Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells.

M Takeuchi1, N Inoue, T W Strickland, M Kubota, M Wada, R Shimizu, S Hoshi, H Kozutsumi, S Takasaki, A Kobata.   

Abstract

Two forms of erythropoietin, EPO-bi and EPO-tetra, with different biological activities were isolated from the culture medium of a recombinant Chinese hamster ovary cell line, B8-300, into which the human erythropoietin gene had been introduced. EPO-bi, an unusual form, showed only one-seventh the in vivo activity and 3 times higher in vitro activity of the previously described recombinant human EPO (standard EPO). In contrast, EPO-tetra showed both in vivo and in vitro activities comparable to those of the standard EPO. EPO-bi, EPO-tetra, and the standard EPO had the same amino acid composition and immunoreactivity. However, structural analyses of their N-linked sugar chains revealed that EPO-bi contains the biantennary complex type as the major sugar chain, while EPO-tetra and the standard EPO contain the tetraantennary complex type as the major sugar chain. From examination of various preparations of recombinant human EPO, we found a positive correlation between the in vivo activity of EPO and the ratio of tetraantennary to biantennary oligosaccharides. These results suggest that higher branching of the N-linked sugar chains is essential for effective expression of in vivo biological activity of EPO.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813359      PMCID: PMC298162          DOI: 10.1073/pnas.86.20.7819

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Erythropoietin and the control of red cell production.

Authors:  S E Graber; S B Krantz
Journal:  Annu Rev Med       Date:  1978       Impact factor: 13.739

2.  Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells.

Authors:  M Takeuchi; S Takasaki; H Miyazaki; T Kato; S Hoshi; N Kochibe; A Kobata
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

3.  Hepatic clearance of intact and desialylated erythropoietin.

Authors:  D W Briggs; J W Fisher; W J George
Journal:  Am J Physiol       Date:  1974-12

4.  Retention of in vitro biological activities by desialylated human luteinizing hormone and chorionic gonadotropin.

Authors:  M L Dufau; K J Catt; T Tsuruhara
Journal:  Biochem Biophys Res Commun       Date:  1971-09       Impact factor: 3.575

5.  Studies on pituitary follitropin. XI. Induction of hormonal antagonistic activity by chemical deglycosylation.

Authors:  M R Sairam; P Manjunath
Journal:  Mol Cell Endocrinol       Date:  1982-10       Impact factor: 4.102

6.  A protein from mammalian liver that specifically binds galactose-terminated glycoproteins.

Authors:  G Ashwell; T Kawasaki
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

7.  Purification of human erythropoietin.

Authors:  T Miyake; C K Kung; E Goldwasser
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

8.  Characterization and biological effects of recombinant human erythropoietin.

Authors:  J C Egrie; T W Strickland; J Lane; K Aoki; A M Cohen; R Smalling; G Trail; F K Lin; J K Browne; D K Hines
Journal:  Immunobiology       Date:  1986-09       Impact factor: 3.144

9.  Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen.

Authors:  J C Egrie; P M Cotes; J Lane; R E Gaines Das; R C Tam
Journal:  J Immunol Methods       Date:  1987-05-20       Impact factor: 2.303

10.  Vesicular stomatitis virus G proteins with altered glycosylation sites display temperature-sensitive intracellular transport and are subject to aberrant intermolecular disulfide bonding.

Authors:  C E Machamer; J K Rose
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

View more
  35 in total

Review 1.  Expression of human glycosyltransferase genes in yeast as a tool for enzymatic synthesis of sugar chain.

Authors:  Yoh-ichi Shimma; Yoshifumi Jigami
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

2.  Solid phase synthesis of the fibronectin glycopeptide V(Gal beta 3GalNAc alpha)THPGY, its beta analogue, and the corresponding unglycosylated peptide.

Authors:  B Lüning; T Norberg; C Rivera-Baeza; J Tejbrant
Journal:  Glycoconj J       Date:  1991-12       Impact factor: 2.916

3.  Kinetic folding mechanism of erythropoietin.

Authors:  Douglas D Banks; Joanna L Scavezze; Christine C Siska
Journal:  Biophys J       Date:  2009-05-20       Impact factor: 4.033

4.  Application of a reversible immortalization system for the generation of proliferation-controlled cell lines.

Authors:  Tobias May; Werner Lindenmaier; Dagmar Wirth; Peter P Mueller
Journal:  Cytotechnology       Date:  2005-11-30       Impact factor: 2.058

5.  Related effects of cell adaptation to serum-free conditions on murine EPO production and glycosylation by CHO cells.

Authors:  François Lefloch; Bertrand Tessier; Sébastien Chenuet; Jean-Marc Guillaume; Pierre Cans; Jean-Louis Goergen; Annie Marc
Journal:  Cytotechnology       Date:  2006-12-29       Impact factor: 2.058

6.  Cloning and expression of a porcine UDP-GalNAc: polypeptide N-acetylgalactosaminyl transferase.

Authors:  A Yoshida; T Hara; H Ikenaga; M Takeuchi
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

7.  Biological and physicochemical characterization of recombinant human erythropoietins fractionated by Mono Q column chromatography and their modification with sialyltransferase.

Authors:  K Morimoto; E Tsuda; A A Said; E Uchida; S Hatakeyama; M Ueda; T Hayakawa
Journal:  Glycoconj J       Date:  1996-12       Impact factor: 2.916

8.  N-glycan analysis of human α1-antitrypsin produced in Chinese hamster ovary cells.

Authors:  Kyung Jin Lee; Sang Mee Lee; Jin Young Gil; Ohsuk Kwon; Jin Young Kim; Soon Jae Park; Hye-Shin Chung; Doo-Byoung Oh
Journal:  Glycoconj J       Date:  2012-10-12       Impact factor: 2.916

9.  Recombinant human erythropoietin (rHuEPO): cross-linking with disuccinimidyl esters and identification of the interfacing domains in EPO.

Authors:  M Haniu; L O Narhi; T Arakawa; S Elliott; M F Rohde
Journal:  Protein Sci       Date:  1993-09       Impact factor: 6.725

Review 10.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.